top of page

Research

Our research group conducts innovative research in nutrition, nanomedicine, and drug delivery. Our research focuses on using biocompatible and biodegradable nanoparticles or transdermal approaches to enhance bioactivities of nutrients and phytochemicals for the prevention and treatment of chronic diseases, especially cardiovascular disease, obesity, and type II diabetes.

Recent Announcements

08/31/2025

Grant Awarded for Two New Projects

Dr. Wang received 2 new grants

1, ASU-Mayo seed grant entitled “Strategies to Reduce the Off-Target Effects of Cardioprotective Agents”

2, NIH R01 grant entitled “Programmed Cell Death 4 in Doxorubicin-Induced Cardiotoxicity”.

Latest Publications

Anti-Obesity and Metabolic Effects of Forskolin in Obese C57BL/6J Mice

Abbasi M, Zhou F, Ly NK, Taylor A, Hu Q, Chi J, Gu H, Wang S. Anti-Obesity and Metabolic Effects of Forskolin in Obese C57BL/6J Mice. Int J Mol Sci. 2025 Jul 10;26(14):6607. doi: 10.3390/ijms26146607. PMID: 40724856; PMCID: PMC12295497.

INNOVATIVE NANO-NUTRION 850 NORTH 5TH STREET, PHOENIX, AZ, 85004, UNITED STATES

bottom of page